Clinical trials
Memory clinical trials
Below are recruiting memory clinical trials, each written for real people, not researchers. We’re tracking 972 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06831461Recruiting
Proton vs photon radiation for brain tumors
This study compares two types of radiation therapy for adults with primary brain tumors that have a good outlook (expected survival longer than 5 years). You will receive either standard photon radiation or the more targeted proton radiation, to see if one works better or causes fewer side effects.
MumbaiAges 18–70 - NCT06831669Recruiting
Predicting rectal cancer treatment response and side effects
This study uses metabolomics (analysis of small molecules in your body) to predict how well your rectal cancer will respond to treatment and whether you may experience side effects. It focuses on patients receiving total neoadjuvant therapy (treatment before surgery).
Guishan, TaoyuanAges 20 years+ - NCT06832761Recruiting
Lifestyle help for people with early memory concerns
This trial tests whether a lifestyle program can help people with mild memory problems (subjective cognitive decline or mild cognitive impairment) who also have at least two things that increase their risk for dementia, like high blood pressure or lack of exercise. If you're 50 or older and have these memory issues and risk factors, you may be able to join.
AmsterdamAges 50 years+ - NCT06833710Recruiting
Ear acupressure for better sleep in nurses
This study tests if applying small acupressure stickers on specific ear points can improve sleep quality for nurses. It may help if you have poor sleep and want a simple, drug-free option.
TaipeiAges 18–65 - NCT06835972RecruitingPhase 1/Phase 2
Abemaciclib and cabozantinib for advanced kidney cancer
This trial tests a new combination of two oral drugs (abemaciclib and cabozantinib) for people with advanced kidney cancer (clear cell type) who have already tried at least two other treatments, including an immunotherapy and a targeted therapy, but their cancer kept growing. The goal is to see if this combination can shrink tumors or slow the cancer.
Baltimore, MarylandAges 18 years+ - NCT06843967RecruitingPhase 1/Phase 2
Mirdametinib and palbociclib for liposarcoma
This trial tests two targeted drugs – mirdametinib and palbociclib – taken as pills for people with a specific aggressive type of liposarcoma (dedifferentiated liposarcoma) that has spread or can't be removed. The goal is to see if this combination can shrink or slow the tumor.
Basking Ridge, New JerseyAges 18 years+ - NCT06851299RecruitingPhase 2
Trop2-ADC alone or with immunotherapy for advanced triple-negative breast cancer
This study tests a new drug called Trop2-ADC, either alone or combined with immunotherapy, for people with advanced triple-negative breast cancer. The goal is to see if it can shrink tumors and improve outcomes.
Guangzhou, GuangdongAges 18–70 - NCT06851988Recruiting
Can exercise boost immunity and reduce head and neck cancer relapse?
This study tests whether a supervised exercise program can boost your immune system and lower the chances of cancer coming back after chemoradiation for head and neck cancer.
New Taipei CityAges 20–80 - NCT06853405Recruiting
Nutrition program to prevent memory decline
This study tests whether nutrition-based changes can help prevent memory loss and thinking problems in people who are at higher risk for dementia. To join, you need to be between 55 and 85, have at least 4 years of schooling, and have an elevated dementia risk score.
Porto, PortugalAges 55–85 - NCT06858982Recruiting
Pitavastatin study for patients on this statin
This study collects information from patients who are already taking pitavastatin, a cholesterol-lowering medication, as recommended by Polish guidelines. The goal is to learn more about how it works in real-world use.
LodzAges 18 years+ - NCT06863233RecruitingPhase 1
Immune cell imaging study for people with lung cancer
This study uses an imaging method to look at certain immune cells (CD8+ T cells) in people with advanced non-small cell lung cancer who are about to receive a new cell therapy. It helps researchers understand how the immune system responds during treatment.
Basking Ridge, New JerseyAges 18 years+ - NCT06868888Recruiting
Red blood cell function in kidney failure
This study looks at how red blood cells work in people with end-stage kidney disease who are on hemodialysis. It aims to understand blood flow and may help guide future treatments.
TaoyuanAges 20 years+ - NCT06873815RecruitingPhase 2
Using a dye to help see cancer during vulvectomy for Paget's disease
This trial tests whether a fluorescent dye called fluorescein sodium can help surgeons see the edges of extramammary Paget's disease more clearly during vulvectomy, so they can remove all the cancer while sparing as much healthy tissue as possible.
Basking Ridge, New JerseyAges 18 years+ - NCT06880861Recruiting
Memory and exercise after young adult cancer treatment
This study looks at how physical activity affects memory in people who had cancer as teenagers or young adults. You'll complete tasks on a computer and wear an activity tracker at home to help researchers learn more.
Scottsdale, ArizonaAges 18 years+ - NCT06882889Recruiting
Comparing domestic vs imported hearing aids for age-related hearing loss
This trial compares two types of hearing aids (one made in China, one imported) to see which works better for age-related hearing loss. You might benefit if you have moderate to severe hearing loss and are willing to test both devices.
Guangzhou, GuangdongAges 60–85 - NCT06889688RecruitingPhase 3
New drug combo vs. chemo for advanced triple-negative breast cancer
This trial tests a new combination of three drugs (camrelizumab, apatinib, and eribulin) against the standard chemotherapy chosen by your doctor. It's for people with advanced triple-negative breast cancer that has gotten worse after previous treatments.
Guangzhou, GuangdongAges 18–70 - NCT06891560RecruitingPhase 2
Enfortumab vedotin for adenoid cystic carcinoma
This trial tests a drug called enfortumab vedotin for people with adenoid cystic carcinoma (ACC) that has spread or come back. The drug is given through a vein and may help shrink tumors or slow the cancer.
Basking Ridge, New JerseyAges 18 years+ - NCT06892093Recruiting
Probiotics to prevent diarrhea from neratinib in breast cancer
This trial tests whether taking probiotics can help prevent diarrhea caused by the breast cancer drug neratinib. If you are a woman with HER2-positive breast cancer and are about to start neratinib, this study may help manage a common side effect.
Guangzhou, GuangdongAges 18 years+ - NCT06918704Recruiting
Digital brain health program for older adults
This study tests a digital program designed to help support thinking and memory in older adults. It may be a good fit if you are 60+ and generally healthy, even if you have some mild memory concerns.
San Francisco, CaliforniaAges 60–85 - NCT06925516RecruitingPhase 2
Apatinib plus immunotherapy and chemo for unresectable bile duct cancer
This study tests a combination of two drugs (apatinib and adebrelimab) with standard chemotherapy for people with bile duct cancer that cannot be removed surgically. The goal is to see if this combination works better than chemotherapy alone.
Guangzhou, GuangdongAges 18–75 - NCT06925724RecruitingPhase 2
Ivonescimab for endometrial and cervical cancer
This trial tests a new drug called ivonescimab for people with advanced endometrial or cervical cancer that has spread or come back after platinum-based chemotherapy. The goal is to see if the drug can help shrink or slow the cancer.
Basking Ridge, New JerseyAges 18 years+ - NCT06928077Recruiting
Power wheelchair training for toddlers with motor delays
This study tests whether adding special visual cues (like lights or arrows) to a power wheelchair helps toddlers with motor delays learn to drive it. If your child is between 1 and 3 years old, can't walk on their own, and can reach for toys, they may be a good fit.
Taoyuan City, Taoyuan CountyAges 10 months–3.3 years - NCT06933095Recruiting
DHA supplement study for older adults with mild memory concerns
This study tests whether a DHA (omega-3) supplement can improve delivery of certain brain fats in older adults who have mild memory concerns. It involves taking a daily supplement and may include a lumbar puncture (spinal tap).
Cincinnati, OhioAges 55–82 - NCT06933394RecruitingPhase 2
Arsenic trioxide with targeted drugs and chemo for high-risk neuroblastoma
This trial tests adding arsenic trioxide to standard chemotherapy and targeted drugs for children with stage 4 or M neuroblastoma. The goal is to see if this combination helps patients who have advanced disease.
Guangzhou, GuangdongAges 1.5 years–18 years
Hear when a new Memory trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for memory?
- Yes. Clin2 currently lists 972 recruiting memory studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a memory trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a memory trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.